Alnylam Pharmaceuticals, Inc. (ALNY)
219.72
-11.46
(-4.96%)
USD |
NASDAQ |
Oct 02, 16:00
220.00
+0.28
(+0.13%)
After-Hours: 20:00
Alnylam Pharmaceuticals Profit Margin (Quarterly) : 12.74% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.74% |
| March 31, 2026 | 17.65% |
| December 31, 2025 | 16.99% |
| September 30, 2025 | 20.10% |
| June 30, 2025 | -9.34% |
| March 31, 2025 | -3.07% |
| December 31, 2024 | -14.12% |
| September 30, 2024 | -22.27% |
| June 30, 2024 | -2.56% |
| March 31, 2024 | -13.34% |
| December 31, 2023 | -31.35% |
| September 30, 2023 | 19.69% |
| June 30, 2023 | -86.59% |
| March 31, 2023 | -54.53% |
| December 31, 2022 | -61.93% |
| September 30, 2022 | -153.6% |
| June 30, 2022 | -123.4% |
| March 31, 2022 | -112.7% |
| December 31, 2021 | -99.97% |
| September 30, 2021 | -109.0% |
| June 30, 2021 | -85.95% |
| March 31, 2021 | -112.8% |
| December 31, 2020 | -148.9% |
| September 30, 2020 | -201.3% |
| June 30, 2020 | -172.4% |
| Date | Value |
|---|---|
| March 31, 2020 | -183.2% |
| December 31, 2019 | -385.3% |
| September 30, 2019 | -297.6% |
| June 30, 2019 | -490.9% |
| March 31, 2019 | -546.4% |
| December 31, 2018 | -1.01K% |
| September 30, 2018 | -11.86K% |
| June 30, 2018 | -546.9% |
| March 31, 2018 | -644.8% |
| December 31, 2017 | -375.0% |
| September 30, 2017 | -719.1% |
| June 30, 2017 | -743.3% |
| March 31, 2017 | -565.9% |
| December 31, 2016 | -647.0% |
| September 30, 2016 | -762.4% |
| June 30, 2016 | -1.03K% |
| March 31, 2016 | -1.40K% |
| December 31, 2015 | -1.20K% |
| September 30, 2015 | -1.21K% |
| June 30, 2015 | -826.5% |
| March 31, 2015 | -273.9% |
| December 31, 2014 | -89.05% |
| September 30, 2014 | -400.9% |
| June 30, 2014 | -604.2% |
| March 31, 2014 | -3.03K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -42.79% |
| BridgeBio Pharma, Inc. | -63.97% |
| Vertex Pharmaceuticals, Inc. | 32.89% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
| Pfizer Inc. | -1.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 109.1% |
| Return on Assets | 16.08% |
| Return on Invested Capital | 22.27% |
| Gross Profit Margin (Quarterly) | 76.88% |
| Operating Margin (Quarterly) | 17.93% |
| Return on Net Operating Assets | 50.15% |